期刊文献+

基于血瘀证探讨活血化瘀法在恶性肿瘤治疗中的应用 被引量:28

Application of Invigorating Blood and Dissolve Stasis in Treating Malignant Tumor Based on Blood Stasis Syndrome
原文传递
导出
摘要 血瘀证是肿瘤患者常见的证候类型之一,现代医学研究表明瘀血是肿瘤形成及转移复发的重要原因,临床证明活血化瘀中药可抑制肿瘤的增殖和转移复发。尽管目前对于活血化瘀中药治疗恶性肿瘤存在争议,但如果辨证准确,适时适量的选用仍可以使肿瘤患者获益。 Blood stasis syndrome is a common syndrome in tumor patients. The studies by both ancient and modern physicians show that blood stasis is a significant cause of neoplasia as well as metastasis. It is clinical proven that blood-invigorating and stasis-dissolving Chinese herbs could inhibit the proliferation,metastasis and recurrence of tumors. Nowadays,there exists controversy in the application of blood-invigorating and stasis-dissolving Chinese herbs in treating malignant tumor. But with accurate syndrome differentiation,the applying of those herbs in proper time and proper quantity could benefit tumor patients.
出处 《中医杂志》 CSCD 北大核心 2017年第8期654-656,共3页 Journal of Traditional Chinese Medicine
关键词 恶性肿瘤 血瘀证 活血化瘀 malignant tumor blood stasis syndrome invigorating blood and dissolving stasis
  • 相关文献

参考文献21

二级参考文献306

共引文献567

同被引文献526

引证文献28

二级引证文献193

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部